NCT03246308

Brief Summary

Research project in which blood samples of patients undergoing UVB phototherapy for the treatment of different cutaneous diseases will be investigated for changes of folate levels and further vitamins over the course of treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

August 8, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 11, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

May 2, 2019

Status Verified

May 1, 2019

Enrollment Period

1.7 years

First QC Date

August 8, 2017

Last Update Submit

May 1, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Folate level

    The change of the folate levels will be measured at baseline and at the end of phototherapy.

    3 years

  • vitamin D level

    The change of vitamin D levels will be measured at baseline and at the end of phototherapy.

    3 years

Interventions

PhototherapyRADIATION

Taking blood sample.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing UVB therapy.

You may qualify if:

  • Patients undergoing UVB phototherapy (narrowband UVB or broadband UVB)
  • Male and female participants minimum 18 years old
  • Written informed consent by the participant after information about the research project

You may not qualify if:

  • Regular sunbed use
  • Underlying disease with abnormal folate metabolism (e.g. thalassemia)
  • Age below 18 years
  • Patients who will not be able to attend regularly for treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna

Vienna, Austria

Location

MeSH Terms

Interventions

Phototherapy

Intervention Hierarchy (Ancestors)

Therapeutics

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD

Study Record Dates

First Submitted

August 8, 2017

First Posted

August 11, 2017

Study Start

August 8, 2017

Primary Completion

May 1, 2019

Study Completion

May 1, 2019

Last Updated

May 2, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations